BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37499299)

  • 1. The influence of sex steroid treatment on insular connectivity in gender dysphoria.
    Reed MB; Handschuh PA; Klöbl M; Konadu ME; Kaufmann U; Hahn A; Kranz GS; Spies M; Lanzenberger R
    Psychoneuroendocrinology; 2023 Sep; 155():106336. PubMed ID: 37499299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-Affirming Hormone Therapy Modifies the CpG Methylation Pattern of the ESR1 Gene Promoter After Six Months of Treatment in Transmen.
    Fernández R; Ramírez K; Gómez-Gil E; Cortés-Cortés J; Mora M; Aranda G; Zayas ED; Esteva I; Almaraz MC; Guillamon A; Pásaro E
    J Sex Med; 2020 Sep; 17(9):1795-1806. PubMed ID: 32636163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray matter volume differences between transgender men and cisgender women: A voxel-based morphometry study.
    Fukao T; Ohi K; Shioiri T
    Aust N Z J Psychiatry; 2022 May; 56(5):535-541. PubMed ID: 33726551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
    van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
    J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross sex hormone treatment is linked with a reversal of cerebral patterns associated with gender dysphoria to the baseline of cisgender controls.
    Kilpatrick LA; Holmberg M; Manzouri A; Savic I
    Eur J Neurosci; 2019 Oct; 50(8):3269-3281. PubMed ID: 30991464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender transition affects neural correlates of empathy: A resting state functional connectivity study with ultra high-field 7T MR imaging.
    Spies M; Hahn A; Kranz GS; Sladky R; Kaufmann U; Hummer A; Ganger S; Kraus C; Winkler D; Seiger R; Comasco E; Windischberger C; Kasper S; Lanzenberger R
    Neuroimage; 2016 Sep; 138():257-265. PubMed ID: 27236082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain sexual differentiation and effects of cross-sex hormone therapy in transpeople: A resting-state functional magnetic resonance study.
    Nota NM; Burke SM; den Heijer M; Soleman RS; Lambalk CB; Cohen-Kettenis PT; Veltman DJ; Kreukels BP
    Neurophysiol Clin; 2017 Dec; 47(5-6):361-370. PubMed ID: 29029883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic network connectivity and own body perception in gender dysphoria.
    Feusner JD; Lidström A; Moody TD; Dhejne C; Bookheimer SY; Savic I
    Brain Imaging Behav; 2017 Aug; 11(4):964-976. PubMed ID: 27444730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
    Glintborg D; T'Sjoen G; Ravn P; Andersen MS
    Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sex hormones on brain GABA and glutamate levels in a cis- and transgender cohort.
    Spurny-Dworak B; Handschuh P; Spies M; Kaufmann U; Seiger R; Klöbl M; Konadu ME; Reed MB; Ritter V; Baldinger-Melich P; Bogner W; Kranz GS; Lanzenberger R
    Psychoneuroendocrinology; 2022 Apr; 138():105683. PubMed ID: 35176535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sex hormone treatment and own-body perception: behavioral and brain connectivity profiles.
    Khorashad BS; Manzouri A; Feusner JD; Savic I
    Sci Rep; 2021 Feb; 11(1):2799. PubMed ID: 33531529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-affirming hormone treatment causes changes in gender phenotype in a 12-lead electrocardiogram.
    Saito N; Nagahara D; Ichihara K; Masumori N; Miura T; Takahashi S
    Heart Rhythm; 2021 Jul; 18(7):1203-1209. PubMed ID: 33706005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
    Hembree WC; Cohen-Kettenis PT; Gooren L; Hannema SE; Meyer WJ; Murad MH; Rosenthal SM; Safer JD; Tangpricha V; T'Sjoen GG
    J Clin Endocrinol Metab; 2017 Nov; 102(11):3869-3903. PubMed ID: 28945902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain network interactions in transgender individuals with gender incongruence.
    Uribe C; Junque C; Gómez-Gil E; Abos A; Mueller SC; Guillamon A
    Neuroimage; 2020 May; 211():116613. PubMed ID: 32057995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gender-affirming hormone therapy on gray matter density, microstructure and monoamine oxidase A levels in transgender subjects.
    Handschuh PA; Reed MB; Murgaš M; Vraka C; Kaufmann U; Nics L; Klöbl M; Ozenil M; Konadu ME; Patronas EM; Spurny-Dworak B; Hahn A; Hacker M; Spies M; Baldinger-Melich P; Kranz GS; Lanzenberger R
    Neuroimage; 2024 Jun; 297():120716. PubMed ID: 38955254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
    Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.
    Nguyen HB; Chavez AM; Lipner E; Hantsoo L; Kornfield SL; Davies RD; Epperson CN
    Curr Psychiatry Rep; 2018 Oct; 20(12):110. PubMed ID: 30306351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-Network Brain Functional Connectivity in Adolescents Assigned Female at Birth Who Experience Gender Dysphoria.
    Skorska MN; Lobaugh NJ; Lombardo MV; van Bruggen N; Chavez S; Thurston LT; Aitken M; Zucker KJ; Chakravarty MM; Lai MC; VanderLaan DP
    Front Endocrinol (Lausanne); 2022; 13():903058. PubMed ID: 35937791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brain characteristics of transgender individuals and consequences of gender assignment treatment].
    López Moratalla N; Calleja Canelas A; Font Arellano M
    Cuad Bioet; 2024; 35(113):91-102. PubMed ID: 38734925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Gender-Affirming Hormone Therapy Requirements.
    Fernandez JD; Kendjorsky K; Narla A; Villasante-Tezanos AG; Tannock LR
    LGBT Health; 2019 Apr; 6(3):101-106. PubMed ID: 30810452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.